| 0.0495 Data as of May 17 |  -0.0015 / -2.94%Today’s Change | 0.03 Today|||52-Week Range 0.16 | +65.00% Year-to-Date |
| Previous close | 0.05 |
| Today’s open | 0.05 |
| Day’s range | 0.05 - 0.06 |
| Volume | 1,525,226 |
| Average volume (3 months) | 2,481,677 |
| Market cap | $27.5M |
| Dividend yield | -- |
| Earnings growth (last year) | 0.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 4.32 |
| Today’s change | Today’s % change | |
|---|---|---|
| CRMECardiome Pharma Corp | +0.03 | +1.42% |
| ASTMAastrom Biosciences ... | -0.02 | -3.39% |
| ECTEEcho Therapeutics In... | +0.02 | +3.39% |
| PTNPalatin Technologies... | +0.02 | +3.23% |
| Last reporting date | June 30, 2010 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$12.1M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Thomas A. Moore |
Chief Financial Officer, Secretary & Senior VP Mark J. Rosenblum, CPA |
Corporate headquarters Princeton, New Jersey |
.
